XBiotech
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $2,620 | $2,620 |
Gross Profit | -435 | -432 | 2,186 | |
EBITDA | -4,364 | -14,531 | -10,421 | -8,153 |
EBIT | -4,803 | -14,966 | -10,853 | -8,196 |
Net Income | -5,015 | -13,006 | -10,002 | -4,635 |
Net Change In Cash | 0 | 0 | 2,620 | 2,620 |
Free Cash Flow | -6,183 | -12,003 | -7,457 | -3,548 |
Cash | 183,118 | 188,530 | 201,039 | 200,023 |
Basic Shares | 30,472 | 30,456 | 30,443 | 30,436 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $300 | $4,010 | $18,394 | $43,997 |
Gross Profit | -1,744 | 3,359 | 12,574 | 9,449 |
EBITDA | -35,766 | -31,876 | -22,434 | -16,038 |
EBIT | -37,510 | -34,490 | -25,082 | -18,276 |
Net Income | -24,557 | -32,900 | -17,414 | -11,221 |
Net Change In Cash | 300 | 4,010 | 18,394 | 43,997 |
Cost of Revenue | -78,716 | -1,088 | -478,600 | |
Free Cash Flow | -19,087 | -15,409 | 65,920 | -68,876 |
Cash | 200,023 | 157,306 | 236,983 | 237,366 |
Basic Shares | 30,438 | 30,439 | 30,043 | 30,823 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.16 |
2024-06-30 | -$0.42 |
2024-03-31 | -$0.32 |
2023-12-31 | -$0.15 |
